STOCK-BASED COMPENSATION |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 26, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STOCK-BASED COMPENSATION | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| STOCK-BASED COMPENSATION | (10) STOCK-BASED COMPENSATION For the thirteen and thirty-nine weeks ended September 26, 2026 and September 27, 2025, stock-based compensation expense (primarily included in “Selling, general, and administrative expenses” in the Condensed Consolidated Statements of Earnings) and associated income tax benefits were as follows:
For the thirteen weeks ended September 26, 2026, the Company granted 532 restricted stock units at a weighted average grant date price of $482.41 per share unit and 1,204 performance stock units at a weighted average grant date price of $474.87 per share unit. For the thirty-nine weeks ended September 26, 2026, the Company granted 8,337 restricted stock units at a weighted average grant date price of $458.46 per share unit and 22,189 performance stock units at a weighted average grant date price of $451.06 per share unit. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||